US Patent 7241796 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
Patent 7241796 was granted and assigned to Vertex Pharmaceuticals on July, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+609 characters)
Article
Patent abstract
The present invention relates to peptidomimetic compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3–NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07241796 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease US Patent 7241796 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
Infobox
Patent Number
0724179600
Patent Number
724179600
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072417960
Date of Patent
July 10, 2007
0Patent Application Number
102809400
Date Filed
October 24, 2002
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072417960
Date of Patent
July 10, 2007
0Patent Application Number
102809400
Date Filed
October 24, 2002
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07241796 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07241796
Date of patent
July 10, 2007
Patent application number
10280940
Date Filed
October 24, 2002
Patent primary examiner
Find more entities like US Patent 7241796 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.